⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

Official Title: Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

Study ID: NCT04730583

Study Description

Brief Summary: This study will evaluate the tolerability and effectiveness of three FDA-approved treatments in Neurofibromatosis Type 1 Cutaneous Neurofibromas. These treatments are: a 1064nm laser, a 755nm laser, and a Kybella injection. Each patient will have a treatment and a control site.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, United States

Contact Details

Name: R. Rox Anderson, MD

Affiliation: Wellman Center for Photomedicine, Massachusetts General Hospital

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: